Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Nasdaq Real Time Price USD

Candel Therapeutics, Inc. (CADL)

Compare
5.09
+0.70
+(15.93%)
At close: April 9 at 4:00:03 PM EDT
5.00
-0.09
(-1.86%)
Pre-Market: 8:15:46 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
--
125
125
Operating Expense
33,371
33,371
38,391
34,799
24,775
Operating Income
-33,371
-33,371
-38,391
-34,674
-24,650
Net Non Operating Interest Income Expense
-1,004
-1,004
-514
-490
-53
Other Income Expense
-20,802
-20,802
966
16,370
-11,421
Pretax Income
-55,177
-55,177
-37,939
-18,794
-36,124
Net Income Common Stockholders
-55,177
-55,177
-37,939
-18,794
-36,124
Diluted NI Available to Com Stockholders
-55,177
-55,177
-37,939
-18,794
-36,124
Basic EPS
-1.74
--
-1.31
-0.65
-1.91
Diluted EPS
-1.74
--
-1.31
-0.65
-1.91
Basic Average Shares
31,675.08
--
28,935.29
28,823.48
18,873.05
Diluted Average Shares
31,675.08
--
28,935.29
28,823.48
18,873.05
Total Operating Income as Reported
-33,371
-33,371
-38,391
-34,722
-25,726
Rent Expense Supplemental
192
192
161
184
250
Total Expenses
33,371
33,371
38,391
34,799
24,775
Net Income from Continuing & Discontinued Operation
-55,177
-55,177
-37,939
-18,794
-36,124
Normalized Income
-34,375
-34,375
-38,905
-35,164
-24,703
Interest Income
1,086
1,086
2,081
1,218
--
Interest Expense
2,090
2,090
2,595
1,708
53
Net Interest Income
-1,004
-1,004
-514
-490
-53
EBIT
-53,087
-53,087
-35,344
-17,086
-24,650
EBITDA
-52,097
-52,097
-34,384
-16,308
-24,418
Reconciled Depreciation
990
990
960
778
232
Net Income from Continuing Operation Net Minority Interest
-55,177
-55,177
-37,939
-18,794
-36,124
Total Unusual Items Excluding Goodwill
-20,802
-20,802
966
16,370
-11,421
Total Unusual Items
-20,802
-20,802
966
16,370
-11,421
Normalized EBITDA
-31,295
-31,295
-35,350
-32,678
-12,997
12/31/2021 - 7/27/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CAPR Capricor Therapeutics, Inc.
9.40
+8.05%
 
VRNA Verona Pharma plc
57.91
+6.90%
 
ALDX Aldeyra Therapeutics, Inc.
1.9400
+1.04%
 
ANVS Annovis Bio, Inc.
1.2900
+5.74%
 
IOVA Iovance Biotherapeutics, Inc.
3.2700
+14.74%
 
SMMT Summit Therapeutics Inc.
18.23
+9.56%
 
IBRX ImmunityBio, Inc.
2.6000
+7.44%
 
MIST Milestone Pharmaceuticals Inc.
0.7233
+10.78%
 
EWTX Edgewise Therapeutics, Inc.
12.50
+8.79%
 
AXSM Axsome Therapeutics, Inc.
101.67
+4.22%